A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL.
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Dana-Farber Cancer Institute
Related studies linked through entity extraction aliases.
A Study of Daratumumab in Patients With Relapsed or Refractory Waldenström Macroglobulinemia
- Status
- COMPLETED
- Phase
- PHASE2
Ear Acupuncture During Chemotherapy Infusion for Breast Cancer, a Feasibility Study
- Status
- COMPLETED
- Phase
- NA
Study of Palbociclib in Combination With Binimetinib for Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Palbociclib After CDK and Endocrine Therapy (PACE)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone and Apalutamide for Rising PSA After RP (FORMULA-509)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
PAZIT Study for Children and Young Adults With Relapsed or Refractory Sarcoma
- Status
- COMPLETED
- Phase
- PHASE1
Ivabradine in the Management of Cardiac Autonomic Dysfunction Associated With Thoracic Radiation Therapy.
- Status
- TERMINATED
- Phase
- PHASE2
Cyclophosphamide and Alemtuzumab In Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Alectinib in RET-rearranged Non-small Cell Lung Cancer or RET-mutated Thyroid Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Abemaciclib for Patients With Retinoblastoma-Positive, Triple Negative Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Osimertinib and Gefitinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- Status
- RECRUITING
- Phase
- PHASE1
LY3022855 With BRAF/MEK Inhibition in Patients With Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study Evaluating the Addition of Pembrolizumab to Radium-223 in mCRPC
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Docetaxel + ARN-509 in Castration-Resistant Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer
- Status
- COMPLETED
- Phase
- NA
Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2